Cargando…

Intranasal NAP (davunetide) decreases tau hyperphosphorylation and moderately improves behavioral deficits in mice overexpressing α-synuclein

Genome-wide association studies have identified strong associations between the risk of developing Parkinson's disease (PD) and polymorphisms in the genes encoding α-synuclein and the microtubule-associated protein tau. However, the contribution of tau and its phosphorylated form (p-tau) to α-s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Magen, Iddo, Ostritsky, Regina, Richter, Franziska, Zhu, Chunni, Fleming, Sheila M, Lemesre, Vincent, Stewart, Alistair J, Morimoto, Bruce H, Gozes, Illana, Chesselet, Marie-Françoise
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2014
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186425/ https://www.ncbi.nlm.nih.gov/pubmed/25505609 http://dx.doi.org/10.1002/prp2.65

Ejemplares similares

NAP (davunetide) preferential interaction with dynamic 3-repeat Tau explains differential protection in selected tauopathies
por: Ivashko-Pachima, Yanina, et al.
Publicado: (2019)

NAP (Davunetide): The Neuroprotective ADNP Drug Candidate Penetrates Cell Nuclei Explaining Pleiotropic Mechanisms
por: Ganaiem, Maram, et al.
Publicado: (2023)

Critical appraisal of the role of davunetide in the treatment of progressive supranuclear palsy
por: Gold, Michael, et al.
Publicado: (2012)

Unexpected gender differences in progressive supranuclear palsy reveal efficacy for davunetide in women
por: Gozes, Illana, et al.
Publicado: (2023)

NAP (davunetide) rescues neuronal dysfunction in a Drosophila model of tauopathy
por: Quraishe, S, et al.
Publicado: (2013)

Tau and Caspase 3 as Targets for Neuroprotection
por: Idan-Feldman, Anat, et al.
Publicado: (2012)

Impairment of mitochondria dynamics by human A53T α-synuclein and rescue by NAP (davunetide) in a cell model for Parkinson’s disease
por: Melo, T. Q., et al.
Publicado: (2016)

The ADNP Syndrome and CP201 (NAP) Potential and Hope
por: Gozes, Illana
Publicado: (2020)

Social Cognition Impairments in Mice Overexpressing Alpha-Synuclein Under the Thy1 Promoter, a Model of Pre-manifest Parkinson’s Disease
por: Magen, Iddo, et al.
Publicado: (2015)

NAP and D-SAL: neuroprotection against the β amyloid peptide (1–42)
por: Gozes, Illana, et al.
Publicado: (2008)

The ADNP Derived Peptide, NAP Modulates the Tubulin Pool: Implication for Neurotrophic and Neuroprotective Activities
por: Oz, Saar, et al.
Publicado: (2012)

Analysis of striatal transcriptome in mice overexpressing human wild-type alpha-synuclein supports synaptic dysfunction and suggests mechanisms of neuroprotection for striatal neurons
por: Cabeza-Arvelaiz, Yofre, et al.
Publicado: (2011)

Risperidone and NAP protect cognition and normalize gene expression in a schizophrenia mouse model
por: Vaisburd, Sinaya, et al.
Publicado: (2015)

The autism/neuroprotection-linked ADNP/NAP regulate the excitatory glutamatergic synapse
por: Sragovich, Shlomo, et al.
Publicado: (2019)

VIP/PACAP-Based Drug Development: The ADNP/NAP-Derived Mirror Peptides SKIP and D-SKIP Exhibit Distinctive in vivo and in silico Effects
por: Sragovich, Shlomo, et al.
Publicado: (2020)

Anti-Inflammatory Properties of NAP in Acute Toxoplasma Gondii-Induced Ileitis in Mice
por: Heimesaat, Markus M., et al.
Publicado: (2015)

Impaired Baroreflex Function in Mice Overexpressing Alpha-Synuclein
por: Fleming, Sheila M., et al.
Publicado: (2013)

Microbiota changes associated with ADNP deficiencies: rapid indicators for NAP (CP201) treatment of the ADNP syndrome and beyond
por: Kapitansky, Oxana, et al.
Publicado: (2020)

Anti-inflammatory Effects of the Octapeptide NAP in Human Microbiota-Associated Mice Suffering from Subacute Ileitis
por: Escher, Ulrike, et al.
Publicado: (2018)

Detection of hyperphosphorylated tau protein and α-synuclein in spinal cord of patients with Alzheimer’s disease
por: Guo, Yanjun, et al.
Publicado: (2016)

Intranasal insulin prevents anesthesia-induced hyperphosphorylation of tau in 3xTg-AD mice
por: Chen, Yanxing, et al.
Publicado: (2014)

Immune-modulatory Properties of the Octapeptide NAP in Campylobacter jejuni Infected Mice Suffering from Acute Enterocolitis
por: Heimesaat, Markus M., et al.
Publicado: (2020)

Tau pathology: predictive diagnostics, targeted preventive and personalized medicine and application of advanced research in medical practice
por: Gozes, Illana
Publicado: (2010)

Sleep Dysfunction and EEG Alterations in Mice Overexpressing Alpha-Synuclein
por: McDowell, Kimberly A., et al.
Publicado: (2018)

The Role of α-synuclein and Tau Hyperphosphorylation-Mediated Autophagy and Apoptosis in Lead-induced Learning and Memory Injury
por: Zhang, Jianbin, et al.
Publicado: (2012)

Hyperphosphorylation-Induced Tau Oligomers
por: Iqbal, Khalid, et al.
Publicado: (2013)

A Novel Microtubule-Tau Association Enhancer and Neuroprotective Drug Candidate: Ac-SKIP
por: Ivashko-Pachima, Yanina, et al.
Publicado: (2019)

Corrigendum: A Novel Microtubule-Tau Association Enhancer and Neuroprotective Drug Candidate: Ac-SKIP
por: Ivashko-Pachima, Yanina, et al.
Publicado: (2021)

Reduction of aluminum ion neurotoxicity through a small peptide application – NAP treatment of Alzheimer’s disease
por: Yang, Ming-Hui, et al.
Publicado: (2019)

Associations Between Amantadine Usage, Gait, and Cognition in PSP: A post-hoc Analysis of the Davunetide Trial
por: Dale, Marian L., et al.
Publicado: (2020)

Brainstem Quadruple Aberrant Hyperphosphorylated Tau, Beta-Amyloid, Alpha-Synuclein and TDP-43 Pathology, Stress and Sleep Behavior Disorders
por: Calderón-Garcidueñas, Lilian, et al.
Publicado: (2021)

Mitochondrial Oxidative Stress Causes Hyperphosphorylation of Tau
por: Melov, Simon, et al.
Publicado: (2007)

Hyperphosphorylated tau in young and middle-aged subjects
por: Elobeid, Adila, et al.
Publicado: (2011)

PINCH in the Cellular Stress Response to Tau-Hyperphosphorylation
por: Ozdemir, Ahmet Yunus, et al.
Publicado: (2013)

Oligomer Formation of Tau Protein Hyperphosphorylated in Cells
por: Tepper, Katharina, et al.
Publicado: (2014)

Immunological memory to hyperphosphorylated tau in asymptomatic individuals
por: Pascual, Gabriel, et al.
Publicado: (2017)

Site-Specific Cerebrospinal Fluid Tau Hyperphosphorylation in Response to Alzheimer’s Disease Brain Pathology: Not All Tau Phospho-Sites are Hyperphosphorylated
por: Barthélemy, Nicolas R., et al.
Publicado: (2022)

Preventive, personalized medicine at the level of key regulatory proteins: updates on activity-dependent neuroprotective protein (ADNP) as a case study
por: Gozes, Illana
Publicado: (2014)

Neuropeptide GPCRs in neuroendocrinology: the case of activity-dependent neuroprotective protein (ADNP)
por: Gozes, Illana
Publicado: (2012)

Activity-dependent neuroprotective protein (ADNP): from autism to Alzheimer’s disease
por: Gozes, Illana
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_cl40drbrgfe4f2n744ai8f9du7